Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

被引:99
作者
Body, J. -J. [2 ]
Bergmann, P. [3 ]
Boonen, S. [4 ]
Boutsen, Y. [5 ]
Devogelaer, J. -P. [6 ]
Goemaere, S. [7 ]
Kaufman, J. -M. [8 ]
Rozenberg, S. [9 ]
Reginster, J. -Y. [1 ,10 ]
机构
[1] CHU Ctr Ville, Bone & Cartilage Metab Res Unit, Policlin L BRULL, B-4020 Liege, Belgium
[2] Univ Libre Bruxelles, Dept Med, CHU Brugmann, Brussels, Belgium
[3] Univ Libre Bruxelles, Dept Radioisotopes, CHU Brugmann, Brussels, Belgium
[4] Katholieke Univ Leuven, Ctr Metab Bone Dis, Louvain, Belgium
[5] Catholic Univ Louvain, Dept Rheumatol, Mont Godinne Univ Hosp, B-1200 Brussels, Belgium
[6] Catholic Univ Louvain, Dept Rheumatol, St Luc Univ Hosp, B-1200 Brussels, Belgium
[7] Univ Ghent, Dept Rheumatol & Endocrinol, B-9000 Ghent, Belgium
[8] State Univ Gent, Dept Endocrinol, Ghent, Belgium
[9] Univ Libre Bruxelles, Dept Gynaecol Obstet, Brussels, Belgium
[10] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
关键词
Bisphosphonate; Osteoporosis; Raloxifene; Strontium; Teriparatide; VITAMIN-D SUPPLEMENTATION; MONTHLY ORAL IBANDRONATE; VERTEBRAL FRACTURE RISK; CONTINUING OUTCOMES RELEVANT; INTRAVENOUS ZOLEDRONIC ACID; STRONTIUM RANELATE; MINERAL DENSITY; NONVERTEBRAL FRACTURES; BREAST-CANCER; PARATHYROID-HORMONE;
D O I
10.1007/s00198-010-1223-4
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.
引用
收藏
页码:1657 / 1680
页数:24
相关论文
共 156 条
[1]
Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]
[2]
Fracture incidence and characterization in patients on osteoporosis treatment: The ICARO study [J].
Adami, Silvano ;
Isaia, Giancarlo ;
Luisetto, Giovanni ;
Minisola, Salvatore ;
Sinigaglia, Luigi ;
Gentilella, Raffaella ;
Agnusdei, Donato ;
Iori, Nicoletta ;
Nuti, Ranuccio .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (10) :1565-1570
[3]
Alekel DL, 2000, AM J CLIN NUTR, V72, P844
[4]
Ipriflavone in the treatment of postmenopausal osteoporosis - A randomized controlled trial [J].
Alexandersen, P ;
Toussaint, A ;
Christiansen, C ;
Devogelaer, JP ;
Roux, C ;
Fechtenbaum, J ;
Gennari, C ;
Reginster, JY .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (11) :1482-1488
[5]
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data [J].
Allen, Matthew R. ;
Burr, David B. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) :61-70
[6]
[Anonymous], 1994, JAMA, V272, P1942
[7]
Costs induced by hip fractures:: A prospective controlled study in Belgium [J].
Autier, P ;
Haentjens, P ;
Bentin, J ;
Baillon, JM ;
Grivegnée, AR ;
Colson, MC ;
Boonen, S .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 (05) :373-380
[8]
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures:: the PERF study [J].
Bagger, YZ ;
Tankó, LB ;
Alexandersen, P ;
Hansen, HB ;
Mollgaard, A ;
Ravn, P ;
Qvist, P ;
Kanis, JA ;
Christiansen, C .
BONE, 2004, 34 (04) :728-735
[9]
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants [J].
Bain, S. D. ;
Jerome, C. ;
Shen, V. ;
Dupin-Roger, I. ;
Ammann, P. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (08) :1417-1428
[10]
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation [J].
Baron, R ;
Tsouderos, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 450 (01) :11-17